François‐Xavier Legrand
- Organic Chemistry top 5%
- Materials Chemistry
- Molecular Biology
- Spectroscopy top 5%
- Biomedical Engineering
- Co-authors
- Sébastien TilloyÉric MonflierPatrick BerthaultGillian BarrattGaspard HuberHervé BricoutSophie FourmentinJérémie Botton
- Topics
- Nanoparticle-Based Drug Delivery (8 papers)Surfactants and Colloidal Systems (6 papers)Nanoparticles: synthesis and applications (5 papers)
- Partner nations
- FranceUnited StatesNorway
In The Last Decade
François‐Xavier Legrand
49 papers receiving 861 citations
Peers
Comparison fields: 5 of 103
- Organic Chemistry 354
- Materials Chemistry 217
- Molecular Biology 208
- Spectroscopy 169
- Biomedical Engineering 138
Countries citing papers authored by François‐Xavier Legrand
This map shows the geographic impact of François‐Xavier Legrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François‐Xavier Legrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François‐Xavier Legrand more than expected).
Fields of papers citing papers by François‐Xavier Legrand
This network shows the impact of papers produced by François‐Xavier Legrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François‐Xavier Legrand. The network helps show where François‐Xavier Legrand may publish in the future.
Co-authorship network of co-authors of François‐Xavier Legrand
This figure shows the co-authorship network connecting the top 25 collaborators of François‐Xavier Legrand. A scholar is included among the top collaborators of François‐Xavier Legrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François‐Xavier Legrand. François‐Xavier Legrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 2 | |
| 6 | 1 | |
| 7 | 3 | |
| 8 | 3 | |
| 9 | 10 | |
| 10 | 2 | |
| 11 | 8 | |
| 12 | 10 | |
| 13 | 20 | |
| 14 | 17 | |
| 15 | 7 | |
| 16 | 6 | |
| 17 | 29 | |
| 18 | 13 | |
| 19 | 8 | |
| 20 | 25 |
About François‐Xavier Legrand
François‐Xavier Legrand is a scholar working on Biomaterials, Pharmaceutical Science and Physical and Theoretical Chemistry, having authored 52 papers that have together received 868 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (8 papers), Surfactants and Colloidal Systems (6 papers) and Nanoparticles: synthesis and applications (5 papers). The work is most often cited by research in Pharmaceutical Science (90 citations), Organic Chemistry (354 citations) and Process Chemistry and Technology (30 citations). François‐Xavier Legrand has collaborated with scholars based in France, United States and Norway. Frequent co-authors include Sébastien Tilloy, Éric Monflier, Patrick Berthault, Gillian Barratt, Gaspard Huber, Hervé Bricout, Sophie Fourmentin, Jérémie Botton, Christine Vauthier and Fanny Varenne. Their work appears in journals such as Nature Communications, The Journal of Immunology and Langmuir.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.